The compound is widely used in the field of biomedical research, particularly in targeted protein degradation studies. It serves as a key component in the development of PROTACs (Proteolysis Targeting Chimeras), which are designed to selectively degrade disease-causing proteins. This approach is especially valuable in cancer research, where it helps eliminate oncogenic proteins that are otherwise difficult to target with traditional small-molecule inhibitors. Additionally, it is employed in chemical biology to study protein function and signaling pathways, offering insights into cellular mechanisms and potential therapeutic interventions. Its role in degrading specific proteins makes it a powerful tool for understanding and treating various diseases.